Product Overview
Tacrolimus Oral Suspension (1mg/mL, 100mL)
Wilcrest’s Tacrolimus Oral Suspension is a ready-to-use formulation manufactured under current good manufacturing practice (CGMP) standards at an FDA-registered 503B outsourcing facility.
A ready-to-use 1mg/mL oral suspension from an FDA-registered 503B outsourcing facility—built to reduce the burden of in-house compounding while supporting consistent dosing.
Preparing Tacrolimus internally can be time-intensive, resource-heavy, and difficult to maintain at scale. Wilcrest’s Tacrolimus Oral Suspension simplifies the process by eliminating hazardous drug manipulation and complex compounding steps, offering a ready-to-use option that integrates seamlessly into pharmacy operations.
Ready to order?
Tacrolimus Oral Suspension (1mg/mL, 100mL)
Wilcrest’s Tacrolimus Oral Suspension is a ready-to-use formulation manufactured under current good manufacturing practice (CGMP) standards at an FDA-registered 503B outsourcing facility.
Built for Real-World Pharmacy Workflows
Why choose a ready-to-use Tacrolimus suspension:
Pharmacist-Led, Formulation-First Development
Wilcrest is led by pharmacists with deep experience in formulation science, regulatory requirements, and pharmacy collaboration. Each product is developed with real-world use in mind—balancing stability, excipient selection, and dosing needs before scaling production.
Tacrolimus Oral Suspension reflects this approach, supported by:
Create an account with Wilcrest to access product details, pricing, and ordering requirements. Registration gives your team the ability to evaluate Tacrolimus Oral Suspension alongside other 503B solutions designed to support pharmacy workflows.